___

• 1- World Health Report 1999: Making a Difference. Geneva, World Health Organization, 1999.
• 2- Murray CJL, Lopez AD: The Global Burden of Disease.Cambridge, MA, Harvard School of Public Health, 1996.
• 3- Onat A, Keleş I, Çetinkaya A, ve ark. On yıllık TEKHARF çalışması verilerine göre Türk erişkinlerinde koroner kökenli ölümlerin prevalansı yüksek. Türk Kardiyol Dern Arş 29: 8-19, 2001
• 4- Türk Kardiyoloji Derneği Koroner Kalp Hastalığı Primer ve Sekonder Koruma Kılavuzu , 2001
• 5- Wilson PW, D'Agostino RB, Levy D,et al: Prediction of coronary heart disease using risk factor catagories.Circulation 97:1837-1847,1998
• 6- D'Agostino RB, Russell MW, Huse DM, et al:Primary and subsequent coronary risk appraisal: New results from the Framingham study. Am Heart J 139: 272-281, 2000
• 7- Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.Arch Intern Med. 1992 Jan;152(l):56-64.
• 8- Ridker PM: Novel risk factors and markers for coronary disease. Adv Intern Med 45: 391-418,2000
• 9- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). National Heart,Lung, and Blood Institute, NIH Publication No. 01-3670, May 2001
• 10- Prof.Dr.Alberti: The new definition is to some extent an amalgam of the three previas major definitions by WFO European Group for Study of Insulin Rezistance and Adult Treatment Panel III 17 May 2005
• 11- Mahley RW, Palaoğlu E, Atak Z, et al: Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-859
• 12- Onat A, Sansoy V. Halkımızda koroner hastalığın başsuçlusu metabolik sendrom: Sıklığı, unsurları, koroner risk ile ilişkisi ve yüksek risk kriterleri. Türk Kardiyoloji Dern Arş 30:8-15,2002
• 13- Witztum JL, Berliner JA: Oxidized phospholipids and isoprostanes in atherosclerosis. Curr Opin Lipidol 9:441-448,1998
• 14- Rong JX, Rangaswamy S, Shen L, et al: Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arterioscler Thromb Vase Biol 18:1885-1894, 1998
• 15- Clarkson TB, Prichart RW,Morgan TM,et al: Remodeling of coronary arteries in human and nonhuman primates. JAMA 271: 289-294, 1994
• 16- Kawamoto A, Gwon HC, Iwaguro H,et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103:634-637, 2001
• 17- Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363,2003
• 18- Türk Kardiyoloji Derneği Koroner Kalp Hastalığı Korunma ve Tedavi Kılavuzu, 2002.
• 19- Brauwald's Heart Disease. Gaziano JM, Manşon JE, Ridker PM: Primary and secondary prevention of coronary heart disease. Elsevier-Saunders, Philadelphia, 2005, Ch 42, 1057-1084.
• 20- Royal Colege of General Practitioners, the Office of Population Censuses and Surveys, and the Department of Health. Morbity Statistics from General Practice, Fourth National Study, 1991-1992. London: Her Majesty's Stationery Office; 1995.
• 21 - Mirvis DM, GoldbergerAL. Electrocardiography. Braunwald's Heart Disease. 7th edition. Elsevier Saunders Company. 2005;107-151.
• 22- Chaitman BR. Exercise Stres Testing. Braunwald's Heart Disease. 7th edition. Elsevier Saunders Company. 2005; 153-185.
• 23- Armstrong WF. Echocardiography. Braunwald's Heart Disease. 7th edition. Elsevier Saunders Company. 2005; 187-270.
• 24- Morrow DA, Gersh BJ, Braunwald E. Chronic Coronary Artery Disease. Braunwald's Heart Disease. 7th edition. Elsevier Saunders Company. 2005; 1281-1354.
• 25- Antman EM. ST-Elevation Myocardial Infarction: Management. Braunwald's Heart Disease. 7th edition. Elsevier Saunders Company. 2005; 1167-1226.
• 26- Mahenthiran J, Bangalore S, Yao SS. et all. Comparison of prognostic value of stress echocardiography versus stress electrocardiography in patients with suspected coronary artery disease. Am J Cardiol.2005 Sepl;96 (5):628-34.
• 27- Han HC. An echocardiogram-based 16 segment model for predicting left ventricular ejection fraction improvement. J Theor Biol. 2004 May 7;228(1):7-15.
• 28- Cemri M. Optimal Değerlendirme İçin Ekokardiyografı Cihaz Ayar- ları.Türkiye Klinikleri Journal of Cardiology 2003; 448-449.
• 29- Smart SC. The clinical utility of echocardiography in the assessment of myocardial viability. J Nucl Med 1994 Apr; 35(4 suppl): 49S-58S.
• 30- Bedetti G, Pasanisi EM, Tintori G, et all. Stress echo in chest pain unit: the SPEED trial. Int J Cardiol. 2005 Jul 20;102(3):461-7.
• 31- Worthley SG,Omar Farouque HM,Helft G,Meredith IT.Coronary artery imaging in the new millennium.Heart,Lung and Circulation 2002;ll:19-25.
• 32- Popma JJ.Coronary Angiography and Intravascular Ultrasound Ima- ging.Braunwauld's Heart Disease A Text Book of Cardiology Seventh Ed.Elsewier Saunders Philadelphia 2005;423-454.
• 33- Baim DS,Grossman W.Cardiac catheterization, angiography, and intervention ,6th ed.Baltimore: Williams & Wilkins, 2000 :211-322.
• 34- Brian P,Griffin E,Topol EJ. Manual of Cardiovascular Medicine Second Edition Lippincott Williams & Wilkins Philadelphia.2004;738-762.
• 35- Wright R, Monnahan R,Kopecky S et al.Cardiac Cathaterization reduces resource utilization in patients with choronic chest pain.Cathater Cardiovasc Interven.2003;49:363.
• 36- Rigatteri S, GhiniAS, Silvestri P, Tomassioni A, Ferraiuolo G, Palamara A, Loschiavo P.A randomized comparison between rotational and standart coronary angiography.Minerva Cardioangiol 2005;53:l-6.
• 37- Apselin P,Fransson SG,.Nephrotoxic effects in high risk patients undergoing angiography. N Eng J Med 2003;348;491.
• 38- Braunwauld E,Antman E,Beasley J.ACC/AHA 2002 guideline update for the manegament of patients with unstable angina. Am J Cardiol 2002;40:1366.
• 39- Bashore TM,et al.American College of Cardiology / Society for Cardiac Angiograhy and Interventions clinical expert consensus document on cardiac catheterization laboratory standarts. J Am Coll of Cardiol 2001;37:2170-2214.
• 40- Apselin P,Aubry P, Fransson SG et al.Nephrotoxicity in high risk patients study of iso-smolar and low osmolar non-ionic contrast media study investigators.N Eng J Med 2003; 348:551-553.
• 41- Shuslerr JM,Grayburn PA.CT imaging of the coronary arteries. Heart. 2005 Dec 30 (Epub ahead of print),
• 42- Scanion PJFaxon DP,Audet AM etal.ACC/AHA guidelines for coronary angiography. A report of American College of Cardiology /American Heart Association Task Force on practice guidelines(Committee on Coronary Angiography).Developed in collaboration with the Society for Cardiac Angiography and Interventions.J Am Coll Cardiol 1999;33:1756-824.
• 43- Leber AW,Knez A,Becker C et al.Non-invasive intravenous coronary angiography using electron beam tomography and multislice computed tomography.Heart 2002;38:633-9.
• 44. Amman P, Bruner LA Roche HP,Angehrn W.Procedural complications following diagnostic coronary angiography are related to the operator's experience and the cathater size.Cathater Cardiovasc Interven.2003;59:13.
• 45- Davidson CJ, Sheikh KH, Harrison JK, et al. Intravascular ultrasonography versus digital subtraction angiography: A human in vivo comparison of vessel size and morphology. J Am Coll Cardiol. 1990 Sep, 16:3,633-6.
• 46- Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol. 1995 Jun, 25:7, 1479-85.
• 47- Hermiller JB, Tenaglia AN, Kisslo KB, et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol. 1993 Mar 15;71(8):665-8.
• 48- Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
• 49- Tuzcu EM, De Franco AC, Goormastic M, et al. Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insight from systematic intravascular ultrasound imaging. J Am Coll Cardiol. 1996;27;832-838.
• 50- Mintz GS, Popma JJ, Pichard AD, et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation. 1995 Apr, 91:7, 1959-65.
• 51- Fitzgerald PJ; Ports TA; Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992 Jul, 86:1, 64-70.
• 52- de Jaegere P, Mudra H, Figulla H, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J. 1998 Aug, 19:8, 1214-23.
• 53- Hayase M, Oshima A, Cleman MW, et al. Relation between target vessel revascularization and mrnumum stent area by intravascular ultrasound (CRUISE Trial). J Am Coll Cardiol 1998;31:386a
• 54- Mudra, Henneke K-H, Zeiher AM, de Jaegere, di Mario C. Acute and preliminary follow-up results of the "OPTimization with ICUS to reduce stent restenosis" OPTICUS Trial. J Am Coll Cardiol. 1998;31(suppl):494A.
• 55- Mintz GS, Pichard AD, Kovach JA, et al. Impact of preintervention intravascular ultrasound imaging on transcatheter treatment strategies in coronary artery disease. Am J Cardiol. 1994 Mar, 73:7, 423-30.
• 56- Burns WB, Hermiller JB, Kisslo K, Culp S, Davidson CJ. Prognostic significance of left main coronary artery disease detected by intravascular ultrasound. J Invasive Cardiol. 1995 May;7(4):119-21.
• 57- Wolfhard U, Gorge G, Konorza T, et al. Intravascular ultrasound (IVUS) examination reverses therapeutic decision from percutaneous intervention to a surgical approach in patients with alteration of the left main stem. Thorac Cardiovasc Surg 1998;46(5):281-4
• 58- Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1997 Jan, 29:1, 6-12.
• 59- Ziada KM, Kim MH, Potts W, et al. Predictors of Target Vessel Revascularization Following Coronary Stent Deployment. J Am Coll Cardiol. 1997;29:239a
• 60- The GUIDE Trial Investigators. IVUS-determined predictors of restenosis in PTCA and DCA: Circulation. 1994;90:4;2:I-23(113).
• 61- Fisher LD, Judkins MP, Lesperance J, et al. Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS). Catheterization and Cardiovascular Diagnosis. 1982;8(6):565-75.
• 62- Hoffman R, Mintz GS, Pompa JJ, et al. Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J. 1998;19(8):1224-31.
• 63- Stone GW, Hodgson JM, St Goar FG, et al. Improved procedural results of coronary angioplasty with intravascular ultrasound-guided balloon sizing: the CLOUT Pilot Trial. Clinical Outcomes With Ultrasound Trial (CLOUT) Investigators. Circulation. 1997;95:2044-2052
• 64- Verstraete SFC, Plokker THW, Ernst S, Mast G, Bal Egbert, Suttorp MJ. Acute Occlusion of the Left Main Coronary Artery Following Intracoronary Ultrasound Examination. Cathet Cardiovasc Intervent. 1999;47:181-184.
• 65- di Mario C, Kovalenkö O, Kobayashi Y, Forzani A, Eberle M, Colombo A. Facilitated Detection of an Edge Dissection after Stenting using the Chroma-Flow System. Intravascular Imaging. 1998 Vol 2 No:l;26-28.
• 66- Spears JR, Marais HJ, Serur J, et al. In vivo coronary angioscopy. J Am Coll Cardiol. 1983;1(15):1311-1314.
• 67- Sherman CT, Litvack F, Grundfest W, et al. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med. 1986;315:913-919
• 68- Uchida Y, Tomaru T, Nakamura F, Furuse A, Fujimori Y, Hasegawa K. percutaneous coronary angioscopy in patients with ischemic heart disease. Am Heart J. 1987; 14:1216-1222
• 69- Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991; 337:809-812
• 70- Uchida Y, Hasegawa K, Kawamura K, Shibuya I. Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal oronary angioplasty. Am Heart J 1989;117(4):769-776.
• 71- Konishi T, inden M, Makano T. Clinical experience of percutaneous coronary angioscopy in cases with coronary artery disease. Angiology. 1989;40(l): 18-23
• 72- Ramee SR, White CJ, Collins TJ, Mesa JE, Murgo JP. Percutaneous angioscopy during coronary angioplasty using a steerable microangioscope. J Am Coll Cardiol. 1991;17(1): 100-105.
• 73- White CJ, Ramee SR, Collins TJ, Mesa JE, Murgo JP. Percutaneous angioscopy of saphenous vein coronary bypass grafts. J Am Coll Cardiol. 1993;21(5):1181-5.
• 74- Lincoff AM, Pompa JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic, and therapeutic profile. J Am Coll Cardiol. 1992;19(5):926-935.
• 75- White CJ, Ramee SR, Collins TJ, Jain SP, Escobar A. Coronary angioscopy of abrupt occlusion after angioplasty. J Am Coll Cardiol 1995;25(7):1681-4.
• 76- Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics in normal and diseased arteries. Am J Cardiol 1993;71:3D-9D
• 77- Wilson RF, Laughlin DE, Holida MD, Hartley CJ, Marcus ML, White CW. Transluminal subselective measurement of coronary blood flow velocity and vasodilator reserve in man. Circulation 1985;72:82-92.
• 78- White CW, Marcus ML, Wilson RF. Methods of measuring coronary flow in humans. Prog Cardiovasc Dis 1988;31:79-94
• 79- Ofıli EO, Karim AM, Kern MJ, Deligönül U, Aguirre F, Serota H, Tatineni S. Simultaneous comparison of intracoronary spectral and zero-cross flow velocity measurements by Doppler angioplasty guidewire and catheter techniques. (Abstr.) J Am Coll Cardiol 1991;17:124A
• 80- Doucette JW, Corld PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guidewire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-1911
• 81- Strauer B. The significance of coronary reserve in clinical heart disease. J Am Coll Cardiol 1990; 15:775-783
• 82- Heuser RR, Strumpf RK, Hardigan K. Use of the Doppler guidewire for intraluminal diagnosis to facilitate coronary intervention. Am Heart J 1993;126:213-218
• 83- Ofili EO, Labovitz AJ, St Vrain JA, Segal J, Aguirre F, Castello R, Kern MJ. Analysis of coronary blood flow dynamics in angiographically normal and stenosed arteries before and after endoluminal enlargement by angioplasty. J Am Coll Cardiol 1993;21:308-316
• 84- Mc Ginn A, White CW, Wiison RF. Interstudy variability of coronary flow reserve: Influence of heart rate, arterial pressure and ventricular preload. Circulation 1990;81:1319-1330
• 85- White CW. Clinical applications of Doppler coronary flow reserve measurements. Am J Cardiol 1993;71:10D-16D
• 86- Donohue TJ, Kern MJ, Aguirre FV, Bach RG, Wolford J, Bell CA. Assessing the hemodynamic significance of coronary artery stenoses: Analysis of translesional pressure flow velocity relations in patients. J Am Coll Cardiol 1993;22:449-458
• 87- Cleary RM, Moore NB, DeBoe SF, Mancini GBJ. Sensitivity and reproducibility of the instantaneous hyperemic flow versus pressure slope index compared to coronary flow reserve for the assessment of stenosis severity. Am Heart J 1993; 126:57-65
• 88- Mancini GBJ, Cleary RM, DeBoe SF, Moore NB, Gallagher KP. Instantaneous hyperemic flow versus pressure slope index. Microsphere validation of an alternative to measures of coronary reserve. Circulation 1991;84:862-870
• 89- Mancini GBJ, McGillem MJ, DeBoe SF, Gallagher KP. The diastolic hyperemic flow versus pressure relation. A new index of coronary stenosis severity and flow reserve. Circulation 1989;80:941-950
• 90- Serruys PW, Di Mario C, Meneveau N, de Jaegere P, Strikwerda S, de Feyter PJ, Emanuelsson H. Intracoronary pressure and flow velocity from sensor tip guide wires. A new methodological comprehensive approach for the assessment of coronary hemodynamics before and after interventions. Am J Cardiol 1993;71:41D-53D
• 91- Di Mario C, Krams R, Gil R, Serruys PW. Slope of the instantaneous hyperemic diastolic coronary flow velocity presure relation. A new index for assessment of the physiological significance of coronary stenoses in humans. Circulation 1994;90:1215-1224
• 92- Wilson RF, Marcus ML, White CW. Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease. Circulation 1987;75:723-732
• 93- Lesser JR, Wilson RF, White CW. Physiologic assessment of coro¬nary stenoses of intermediate severity can facilitate patient selection for coronary angioplasty. Coronary Arter Dis 1990;l:697-705
• 94- Kern MJ, Donohue TJ, Aguirre FV, Bach RG, Caracciolo EA, Wolford T, Mechem CJ, Flynn MS, Chaitman B. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 1995;25:178-187
• 95- Segal J, Kern MJ, Scott NA, King SB, Doucette JW, Heuser RR, Ofili EO, Siegel R. Alteration of phasic coronary arteiy flow velocity in humans during percutaneous coronary angioplasty. J Am Coll Cardiol 1992;20:276-286
• 96- Wilson RF, Johnson MJ, Marcus ML, Aylward PE, Shorton DJ, Collins S, White CW. The effect of coronary angioplasty on coronary flow reserve. Circulation 1988;76:873-885
• 97- Serruys PW, Di Mario C, Piek J, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Miihlberger V, Danzi G, Peels HO, Ford AJ, Boersma E. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short and long-term outcomes of coronary baloon angioplasty. The DEBATE Study (Doppler End-points Baloon Angiolasty Trial Europe). Circulation 1997;96:3369-3377
• 98- Kern MJ, Donohue TJ, Aguirre FV, Bach RG, Caracciolo EA, Ofili E, Labovitz AJ. Assessment of angiographically intermediate coronary artery stenoses using the Doppler flowire. Am J Cardiol 1993;71:26D-33D
• 99- Miller DD, Donohue TJ, Younis LT, Bach RG, Aguirre FV, Wittry MD, Goodgold HM, Chaitman BR, Kern MJ. Correlation of pharmacological Tc 99m-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary stenoses. Circulation 1994;89:2150-2160
• 100- Joye JD, Schulman DS, Lasorda D, Farah T, Donohue BC, Reichek N. Intracoronary Doppler guide wire versus stress singlephotan emission computed tomographic Thallium-201 imaging in assessment of intermediate coronary stenoses. J Am Coll Cardiol 1994;24:940-947
• 101- Heller LI, Cates C, Popma J, Deckelbaum LI, Joye JD, Dahlberg ST, Villegas BJ, Arnold A, Kipperman R, Grinstead WC, Balcom S, Ma Y, Cleman M, Steingard RM, Leppo JA. Intracoronary Doppler assessment of moderate coronary artery disease. Comparison with Tl-201 imaging and coronary angiography. Circulation 1997;96:484-490
• 102- Aueron FM, Gruentzig AR. Percutaneous transluminal coronary angioplasty. Indication and current status. Primary Cardiol 1984;10:97-107
• 103- Kern MJ, De Bruyne B, Pijls NHJ. From research to clinical practice: Current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. J Am Coll Cardiol 1997;30:613-20
• 104- Pijls NHJ, Bech GJW, De Bruyne B, Van Straten A. Clinical assessment of functional stenosis severity: Use of coronary pressure measurements for the decision to bypass a lesion. Ann Thorac Surg 1997;63:S6-11
• 105- Pijls NHJ, Van Son JAM, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary myocardial and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after PTCA. Circulation 1993;87:1354-1367
• 106- Van der Voort PH, Van Hagen E, Hendrix G, Van Gelder B, Bech JW, Pijls NHJ. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn 1996;39:120-125
• 107- Pijls NHJ, Van Gelder B, Van der Voort P, Peels K, Bracke FALE, Bonnier HJRM, El Gamal MIH. Fractional Flow Reserve. A Useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995;92:3183-3193
• 108- Pijls NHJ, Bech GJM, El Gamal MIH. Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events. J Am Coll Cardiol 1995;25:1522-8
• 109- Fractional flow reserve in normal coronary arteries. In: Pijls NHJ, De Bruyne B, editors. Coronary Pressure. The Netherlands: Kluwer Academic Publishers, 1997:179-187
• 110- Pijls NHJ, De Bruyne B, Peels K, Van der Voort PH, Bonnier HJRM, Bartunek J, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med 1996;334:1703-8
• 111- De Bruyne B, Bartunek J, Sys SU, Pijls NHJ, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow vesus pressure slope index and fractional flow reserve. Circulation 1996;94:1842-1849
• 112- Bech GJW, Pijls NHJ, De Bruyne B, Peels KH, Michels HR, Bonnier HJRM, Koolen JJ. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 1999;99:883-888
• 113- Pijls NHJ, Bech GJW, De Bruyne B ve ark. Prognostic value of pressure-derived fractional flow reserve to predict restenosis after regular balloon angioplasty (abstract). Circulation 1997;96:I-649
• 114- Serruys PW, De Jaegere P, Kiemeneij F ve ark. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495
• 115- Fischman DL, Leon MB, Baim DS ve ark. A randomized comparison of coronary stent placement and balloon angioplasty in the treatmnet of coronary artery disease. N Engl J Med 1994;331:496- 501
• 116- Hanekamp CEE, Koolen JJ, Pijls NHJ, Michels HR, Bonnier HJRM. Comparison of quantitative coronary angiography, intravascular ultrasound and coronary pressure measurement to assess optimum stent deployment. Circulation 1999;99:1015-1021
• 117- Bech GJW, De Bruyne B, Bonnier HJRM, Bartunek J, Wijns W, Peels K, Hetndrickx GR, Koolen JJ, Pijls NHJ. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol 1998;31:841-7
• 118- Pijls NHJ, De Bruyne B. Coronary pressure mesurement and fractional flow reserve. Heart 1998;80:539-542
• 119- Muller JE, Toiler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79(4):733-43.
• 120- Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983;50(2): 127-34.
• 121- Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69(5):377-81.
• 122- Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vase Biol. 2000;20(5): 1262-75.
• 123- Komiyama N, Berry GJ, Kolz ML, Oshima A, Metz JA, Preuss P, Brisken AF, Pauliina Moore M, Yock PG, Fitzgerald PJ. Tissue characterization of atherosclerotic plaques by intravascular ultrasound radiofrequency signal analysis: an in vitro study of human coronary arteries. Am Heart J. 2000;140(4):565-74.
• 124- de Korte CL, Cespedes El, van der Steen AF, Pasterkamp G, Bom N. Intravascular ultrasound elastography: assessment and imaging of elastic properties of diseased arteries and vulnerable plaque. Eur J Ultrasound. 1998 Aug;7(3):219-24.
• 125- de Korte CL, Pasterkamp G, van der Steen AF, Woutman HA, Bom N. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro. Circulation. 2000;102(6):617-23.
• 126- Brezinski ME, Tearney GJ, Bouma BE, Izatt JA, Hee MR, Swanson EA, Southern JF, Fujimoto JG. Optical coherence tomography for optical biopsy. Properties and demonstration of vascular pathology. Circulation. 1996;93(6): 1206-13.
• 127- Tearney GJ, Brezinski ME, Boppart S A, Bouma BE, Weissman N, Southern JF, Swanson E A, Fujimoto JG. Images in cardiovascular medicine. Catheter-based optical imaging of a human coronary artery. Circulation. 1996;94(ll):3013.
• 128- Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB, Choi KB, Shishkov M, Schlendorf K, Pomerantsev E, Houser SL, Aretz HT, Tearney GJ. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol. 2002;39(4):604-9.
• 129- Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Kang DH, Halpern EF, Tearney GJ. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002;106(13):1640-5.
• 130- Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347(9013): 1447-51.
• 131- Stefanadis C, Toutouzas K, Vavuranakis M, Tsiamis E, Tousoulis D, Panagiotakos DB, Vaina S, Pitsavos C, Toutouzas P. Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques. Eur Heart J. 2002;23(21):1664-9.
• 132- Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, Stefanadi E, Toutouzas P. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Circulation. 1999;99(15):1965-71.
• 133- Stefanadis C, Toutouzas K, Tsiamis E, Stratos C, Vavuranakis M, Kallikazaros I, Panagiotakos D, Toutouzas P. Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol. 2001;37(5):1277-83.
• 134- Brennan JF 3rd, Romer TJ, Lees RS, Tercyak AM, Kramer JR Jr, Feld MS. Determination of human coronary artery composition by Raman spectroscopy. Circulation. 1997;96(l):99-105.
• 135- Moreno PR, Lodder RA, Purushothaman KR, Charash WE, O'Connor WN, MuHer JE. Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation. 2002 Feb 26;105(8):923-7.
• 136- Bosshart F, Utzinger U, Hess OM, Wyser J, Mueller A, Schneider J, Niederer P, Anliker M, Krayenbuehl HP. Fluorescence spectroscopy for identification of atherosclerotic tissue. Cardiovasc Res. 1992;26(6):620-5.
• 137- Romer TJ, Brennan JF 3rd, Fitzmaurice M, Feldstein ML, Deinum G, Myles JL, Kramer JR, Lees RS, Feld MS. Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy. Circulation. 1998;97(9):878-85.
• 138- Romer TJ, Brennan JF 3rd, Puppels GJ, Zwinderman AH, van Duinen SG, van der Laarse A, van der Steen AF, Bom NA, Bruschke AV. Intravascular ultrasound combined with Raman spectroscopy to localize and quantify cholesterol and calcium salts in atherosclerotic coronary arteries. Arterioscler Thromb Vase Biol. 2000;20(2):478-83.
• 139- Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, Aguinaldo JG, Badimon JJ, Sharma SK. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102(5):506-10.
• 140- Correia LC, Atalar E, Kelemen MD, Ocali O, Hutchins GM, Fleg JL, Gerstenblith G, Zerhouni EA, Lima JA. Intravascular magnetic resonance imaging of aortic atherosclerotic plaque composition. Arterioscler Thromb Vase Biol. 1997;17(12):3626-32.
• 141- Schmermund A, Mohlenkamp S, Erbel R.The latest on the calcium story. Am J Cardiol. 2002; 21:90 (10C):12L-14L.
• 142- Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001; 103:934-40.
• 143- Burke APKolodgie FD, Farb a, Weber D, Virmani R. Morphological predictors of arterial remodelling. Circulation 2002; 105:297-303.
• 144- Schoenhagen P, Halliburton SS, Stillman AE, Kuzmiak SA, Nissen SE, Tuzcu EM, White RD. Noninvasive Imaging of Coronary Arteries: Current and Future Role of Multi-Detector Row CT. Radiology 2004; 232:7-17.
• 145- Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
• 146- Schoenhagen P, Halliburton SS, Stillman AE, Kuzmiak SA, Nissen SE, Tuzcu EM, White RD. Noninvasive Imaging of Coronary Arteries: Current and Future Role of Multi-Detector Row CT. Radiology 2004; 232:7-17.
• 147- Becker CR. Estimation of cardiac event risk by MDCT. Eur Radiol Suppl2005; 15(Suppl 2):B17-B22.
• 148- Wexler L, Brundage B, Crouse et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health proffesionals from the American heart Association. Circulation 1996; 94: 1175-1192.
• 149- Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary Artery Calcium Area by Electron-Beam Computed Tomography and Coronary Atherosclerotic Plaque Area. A Histopathologic Correlative Study. Circulation. 1996:1;94:588.
• 150- Wayhs et al High coronary artery calcium scores pose an extremely elavated risk risk for hard events. J Am Coll Cardiol 2000;39: 225-230
• 151 Shaw LJ et al. Prognostic Value of Cardiac Risk Factors and Coronary Artery Calcium Screening for All-Cause Mortality Radiology 2003; 228:826-833.
• 152- Greenland P, et al.Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals. JAMA, 2004; 291: 210 - 215.
• 153- Herzog C, et al. Multidetector-row cardiac CT: diagnostic value of calcium scoring and CT coronary angiography in patients with symptomatic, but atypical, chest pain. Eur Radiol. 2004 ;14:169-77.
• 154- Erbel R. Dawn of a new era: Noninvasive coronary imaging. Hertz. 1996;21:75-77.
• 155- Nieman K,Cademartiri F, Lemos PA, Raaijmakers R, Pattynama PM, de Feyter PJ. Reliable noninvasive coronary angiography with fast submilimeter multislice spiral computed tomography. Circula¬tion 2002; 106:2051-54.
• 156- Cury RC, Ferencik M, Achenbach S, Pomerantsev E, Nieman K, Moselewski F, Abbara S, Jang IK, Brady TJ, Hoffmann U. Accuracy of 16-slice multi-detector CT to quantify the degree of coronary artery stenosis: Assessment of cross-sectional and longitudinal vessel reconstructions. Eur J Radiol. 2006 Jan 24;elektronik baskı, baskıda
• 157. Lebowitz E, Greene MV, Fairchild R et al. Thallium 201 for medical use. J Nucl Med 1975;16:151-55
• 158. Administration of Radioactive Substance Advisory Commitee. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Didcot, UK:ARSAC Support Unit, National Radiological Protection Board, 1998
• 159. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.JAMA. 1998 Sep 9;280(10):913-20
• 160. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, Maddahi J, Germano G. Separate acquisition rest thallium-201/ stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.J Am Coll Cardiol. 1993 Nov 1;22(5): 1455-64
• 161. Kiat H, Van Train KF, Maddahi J, Corbett JR, Nichols K, McGhie AI, Akers MS, Friedman JD, Roy L, Berman DS.Development and prospective application of quantitative 2-day stress-rest Tc-99m methoxy isobutyl isonitrile SPECT for the diagnosis of coronary artery disease. Am Heart J. 1990 Dec; 120(6 Pt 1): 1255-66
• 162. Taillefer R, Depuey EG, Udelson JE et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in womenJ Am Coll Cardiol. 1997 Jan;29(l):69-77
• 163. Kapur A, Latus KA, Davies G, Dhawan RT, Eastick S, Jarritt PH, Roussakis G, Young MC, Anagnostopoulos C, Bomanji J, Costa DC, Pennell DJ, Prvulovich EM, Ell PJ, Underwood SR. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study.Eur J Nucl Med Mol Imaging. 2002 Dec; 29(l 2): 1608-16
• 164. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.
• 165. Turgut B, Unlu M, Cengel A. Dobutamine stress tetrofosmin SPECT; evaluation of short rest-stress protocol and head to head comparison with MIBI in detection of coronary artery disease. Ann Nucl Med. 2005 Apr; 19(2): 115-22
• 166. Heller GV, Bateman TM, Johnson LL, Cullom SJ, Case JA, Gait JR, Garcia EV, Haddock K, Moutray KL, Poston C, Botvinick EH, Fish MB, Follansbee WP, Hayes S, Iskandrian AE, Mahmarian JJ, Vandecker W Clinical value of attenuation correction in stressonly Tc-99m sestamibi SPECT imaging. J Nucl Cardiol. 2004 MayJun;ll(3):273-81.
• 167. Thomas GS, Miyamoto MI, Hachamovitch R, Shaw LJ et al. Technetium 99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting. The Nuclear Utility in the Community (NUC) Study.J Am Coll Cardiol. 2004 Jan21;43(2):213-23
• 168. Lette J, Lapointe J, Waters D, Cerino M, Picard M, Gagnon A. Transient left ventricular cavitary dilation during dipyridamolethallium imaging as an indicator of severe coronary artery disease. Am J Cardiol 1990; 66: 1163-70
• 169. Emory Review course Atlanta 1994
• 170. DS Schulman, JM Lazar, G Ziady, DJ Grandis, AR Flores, and JE Orie Right ventricular thallium-201 kinetics in pulmonary hypertension: relation to right ventricular size and function J Nucl Med 1993 34: 1695-1700).
• 171. Hachamovitch R, Berman DS, Shaw LJ et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998 Feb 17;97(6):535-43.
• 172. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO Jr, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO; American College of Cardiology; American Heart Association; American Society for Nuclear Cardiology. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).J Am Coll Cardiol. 2003 Oct l;42(7):1318-33.
• 173. Gibbons RS. American Society of Nuclear Cardiology project on myocardial perfusion imaging: measuring outcomes in response to emerging guidelines.J Nucl Cardiol. 1996 Sep-Oct;3(5):436-42.
• 174. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, Agafitei RD, Friedman JD, Berman DS. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction.J Nucl Med. 2001 Jun;42(6):831-7
• 175. Klein W et al. Cardiovascular disease at the turn of the millenium: focus on Europe. Eur Heart J 2001 ;3 ( suppl ):M2-M6
• 176. Cerqueira MD. Diagnostic testing strategies for coronary artery disease: special issues related to gender.Am J Cardiol. 1995 Apr 13;75(ll):52D-60D.
• 177. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, Hachamovitch R, Shaw LJ. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus.Am Heart J. 1999 Dec; 138(6 Ptl):1025-32
• 178. Shaw LJ, Miller D. Noninvasive Coronary Risk Stratification of Elderly Patients.Am J Geriatr Cardiol. 1994 Jan;3(l):12-21, Steingart RM, Hodnett P, Musso J, Feuerman M. Exercise myocardial perfusion imaging in elderly patients.J Nucl Cardiol. 2002 Nov-Dec; 9(6):573-80
• 179. Hilton TC, Shaw LJ, Chaitman BR, Stocke KS, Goodgold HM, Miller DD. Prognostic significance of exercise thallium-201 testing in patients aged greater than or equal to 70 years with known or suspected coronary artery disease. Am J Cardiol. 1992 Jan l;69(l):45-50
• 180. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patient with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis.J Am Soc Nephrol. 2003 Feb;14(2):431-9
• 181. Eichstadt HW, Eskotter H, Hoffman I, Amthauer HW, Weidinger G. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.Am J Cardiol. 1995 Jul 13;76(2):122A-125A. Mahmarian JJ, Fenimore NL, Marks GF, Francis MJ, Morales-Ballejo H, Verani MS, Pratt CM. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol. 1994 Jul;24(l):25-32
• 182. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, Marcus ML. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?N Engl J Med. 1984 Mar 29;310(13):819-24
• 183. Cingi E, Temiz NH, Yildirim N, Timurkaynak T, Cengel A, Unlu M. Detection of stent restenosis in single vessel CAD: comparison of 201T1 and gated 99mTc-MIBI SPECT.Nucl Med Commun. 2004 May;25(5):479-86
• 184. Flotats A, Carrio I. Cardiac neurotransmission SPECT imaging. J Nucl Cardiol. 2004 Sep-Oct;ll(5):587-602.
• 185. Sciagra R, Pellegri M, Pupi A et al. Prognostic implications of 99mc-sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic CAD disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739
• 186. Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, Jager PL. Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging. 2006 Feb;22(l):63-80
• 187. Gokgoz L, Gunaydin S, Unlu M. Decision-making for surgery in patients with end-stage coronary artery disease: the role of dual isotope myocardial perfusion SPECT after dobutamine infusion. Acta Cardiol. 1994;49(2): 183-9
• 188. Schelbert HR. 18F-deoxyglucose and the assessment of myocardial viability. Semin Nucl Med. 2002 Jan;32(l):60-9
• 189. Pagano D, Lewis ME, Townend JN, Davies P, Camici PG, Bonser RS. Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival.Heart. 1999 Dec;82(6):684-8.
• 190. Bax JJ, Van Der Wall EE, De Roos A, Poldermans D. In:Zaret BI," Beller GA editors. Clinical nuclear cardiology. State of the art and future directions. 3rd edn. Philadelphia:Mosby;2005, p535
• 191. Ünlü M. Kardiyolojide Pozitron Emisyon Tomografisi Uygulamaları T Klin J Cardiol 2003; 16(1): 50-58.